R1 RCM Inc
NASDAQ:RCM

Watchlist Manager
R1 RCM Inc Logo
R1 RCM Inc
NASDAQ:RCM
Watchlist
Price: 40 USD -4.76% Market Closed
Market Cap: 16.9B USD
Have any thoughts about
R1 RCM Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one RCM stock under the Base Case scenario is 24.29 USD. Compared to the current market price of 40 USD, R1 RCM Inc is Overvalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RCM Relative Value
Base Case
24.29 USD
Overvaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6.9
P/S
P/S
Price to Sales
6.9
vs History
0
vs Industry
44
Median 3Y
3.3
Median 5Y
2.6
Industry
2.3
Forward
6.6
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
0
Median 3Y
-79.2
Median 5Y
-13.2
Industry
23.1
Forward
-189.1
More Details
57.9
P/OCF
P/OCF
Price to OCF
57.9
vs History
17
vs Industry
24
Median 3Y
25.2
Median 5Y
25.2
Industry
14.2
More Details
25
P/FCFE
P/FCFE
Price to FCFE
25
vs History
23
vs Industry
6
Median 3Y
8.9
Median 5Y
8.9
Industry
20.1
More Details
6
P/B
P/B
Price to Book Value
6
vs History
34
vs Industry
43
Median 3Y
2.3
Median 5Y
4.2
Industry
2.2
More Details
7.7
EV/S
EV/S
Enterprise Value to Sales
7.7
vs History
1
vs Industry
37
Median 3Y
4.2
Median 5Y
3.4
Industry
2.4
Forward
7.3
More Details
39.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
39.9
vs History
0
vs Industry
14
Median 3Y
20.9
Median 5Y
17
Industry
5
More Details
36.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
36.7
vs History
1
vs Industry
27
Median 3Y
20.2
Median 5Y
16.7
Industry
12.7
Forward
32.8
More Details
94.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
94.9
vs History
0
vs Industry
16
Median 3Y
40.3
Median 5Y
34.8
Industry
17.1
Forward
201.8
More Details
64.7
EV/OCF
EV/OCF
Enterprise Value to OCF
64.7
vs History
15
vs Industry
20
Median 3Y
27.7
Median 5Y
28.1
Industry
14
More Details
101.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
101.1
vs History
17
vs Industry
16
Median 3Y
33.6
Median 5Y
36.2
Industry
18
More Details
3.4
EV/IC
EV/IC
Enterprise Value to IC
3.4
vs History
26
vs Industry
47
Median 3Y
1.6
Median 5Y
1.9
Industry
1.9
More Details

Multiples Across Competitors

RCM Competitors Multiples
R1 RCM Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
US
Cigna Corp
NYSE:CI
78.7B USD 0.3 25.9 8.1 10.4
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.8B EUR 1.3 48.1 11.2 25.8
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49 9.3 18.9
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.4 13.2 20.5
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.5 12.3 16.7
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.8B EUR 0.7 24.1 7 16.3
US
DaVita Inc
NYSE:DVA
12.9B USD 1 15.5 8 11.2
AU
Sonic Healthcare Ltd
ASX:SHL
13.1B AUD 1.5 25.6 19.2 19.2
P/E Multiple
Earnings Growth PEG
US
R1 RCM Inc
NASDAQ:RCM
Average P/E: 26.8
Negative Multiple: -275.9
253%
N/A
US
Cigna Corp
NYSE:CI
25.9
25%
1
US
C
Cigna Group
XMUN:CGN
25.9
25%
1
US
CVS Health Corp
NYSE:CVS
11.3
3%
3.8
DE
Fresenius Medical Care AG
XMUN:FME
48.1
31%
1.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.4
54%
0.8
US
Quest Diagnostics Inc
NYSE:DGX
20.5
12%
1.7
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.1
31%
0.8
US
DaVita Inc
NYSE:DVA
15.5
17%
0.9
AU
Sonic Healthcare Ltd
ASX:SHL
25.6
11%
2.3

See Also

Summary
RCM intrinsic value, competitors valuation, and company profile.
DCF Valuation
RCM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RCM stock valuation using valuation multiples.
Wall Street Estimates
RCM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RCM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.